References
- RogerVLGoASLloyd-JonesDMAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2012 update: a report from the American Heart AssociationCirculation20121251e2e22022179539
- JacksonRVLaffertyATorpyDJStratakisCNew genetic insights in familial hyperaldosteronismAnn N Y Acad Sci2002970778812381543
- FalloFPilonCWilliamsTACoexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronismJ Hum Hypertens2004181475114688810
- LiftonRPDluhyRGPowersMA chimaeric 11 beta- hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertensionNature199235563572622651731223
- NewMILevineLSBiglieriEGPareiraJUlickSEvidence for an unidentified steroid in a child with apparent mineralocorticoid hypertensionJ Clin Endocrinol Metab1977445924933870517
- QuinklerMBappalBDraperNMolecular basis for the apparent mineralocorticoid excess syndrome in the Oman populationMol Cell Endocrinol20042171–214314915134813
- OdermattADickBArnoldPA mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertensionJ Clin Endocrinol Metab20018631247125211238516
- HammerFStewartPMCortisol metabolism in hypertensionBest Pract Res Clin Endocrinol Metab200620333735316980198
- QuinklerMStewartPMHypertension and the cortisol-cortisone shuttleJ Clin Endocrinol Metab20038862384239212788832
- ZachmannMTassinariDPraderAClinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patientsJ Clin Endocrinol Metab19835622222296296182
- WhitePCCurnowKMPascoeLDisorders of steroid 11 beta-hydroxylase isozymesEndocr Rev19941544214387988480
- CurnowKMSlutskerLVitekJMutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8Proc Natl Acad Sci U S A19939010455245568506298
- WhitePCDupontJNewMILeibermanEHochbergZRöslerAA mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan originJ Clin Invest1991875166416672022736
- AuchusRJGenetic deficiencies of cytochrome P450c17 (CYP17A1): combined 17-hydroxylase/17,20-lyase deficiency and isolated 17,20-lyase deficiencyNewMIParsaAHammerGDGenetic Steroid DisordersWaltham, MAElsevier2014111123
- Costa-SantosMKaterCEAuchusRJBrazilian Congenital Adrenal Hyperplasia Multicenter Study GroupTwo prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiencyJ Clin Endocrinol Metab2004891496014715827
- LiftonRPGharaviAGGellerDSMolecular mechanisms of human hypertensionCell2001104454555611239411
- CharmandariEIchijoTJubizWA novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expressionJ Clin Endocrinol Metab200893124963449818827003
- LiddleGWBledsoeTCoppageWSA familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretionTrans Assoc Am Physicians196376199213
- ShimketsRAWarnockDGBositisCMLiddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channelCell19947934074147954808
- AbrielHLoffingJRebhunJFDefective regulation of the epithelial Na+ channel by Nedd4 in Liddle’s syndromeJ Clin Invest1999103566767310074483
- WilsonFHDisse-NicodèmeSChoateKAHuman hypertension caused by mutations in WNK kinasesScience200129355321107111211498583
- BoydenLMChoiMChoateKAMutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesNature201248273839810222266938
- ChoiMSchollUIYuePK+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertensionScience2011331601876877221311022
- HiramatsuKYamadaTYukimuraYA screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patientsArch Intern Med198114112158915937030245
- FunderJWCareyRMFardellaCEndocrine SocietyCase detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab20089393266328118552288
- AuchusRJWiansFHAndersonMEWhat we still do not know about adrenal vein sampling for primary aldosteronismHorm Metab Res201042641144520411476
- RossiGPBarisaMAllolioBThe Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronismJ Clin Endocrinol Metab20129751606161422399502
- YoungWFStansonAWWhat are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?Clin Endocrinol (Oxf)2009701141719128364
- AuchusRJChandlerDWSingeethamSMeasurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronismJ Clin Endocrinol Metab20079272648265117473070
- NakamuraYSatohFMorimotoR18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronismJ Clin Endocrinol Metab2011968E1272E127821593107
- AuchusRJMichaelisCWiansFHJrRapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronismAnn Surg2009249231832119212188
- BetzMJDegenhartCFischerEAdrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success ratesEur J Endocrinol2011165230130621602315
- IronyIKaterCEBiglieriEGShackletonCHCorrectable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenomaAm J Hypertens1990375765822194512
- JacksonBValentineRWagnerGPrimary aldosteronism due to a malignant ovarian tumourAust N Z J Med198616169713518689
- TodescoSTerribileVBorsattiAManteroFPrimary aldosteronism due to a malignant ovarian tumorJ Clin Endocrinol Metab1975415809819171276
- MonticoneSHattangadyNGNishimotoKEffect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cellsJ Clin Endocrinol Metab2012978E1567E157222628608
- OkiKPlonczynskiMWLuis LamMGomez-SanchezEPGomez-SanchezCEPotassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesisEndocrinology201215341774178222315453
- SchollUINelson-WilliamsCYuePHypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5Proc Natl Acad Sci U S A201210972533253822308486
- BeuschleinFBoulkrounSOsswaldASomatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertensionNat Genet2013454440444 444e123416519
- NeriGDe ToniRTortorellaCOuabain chronic infusion enhances the growth and steroidogenic capacity of rat adrenal zona glomerulosa: the possible involvement of the endothelin systemInt J Mol Med200618231531916820940
- HajnóczkyGCsordásGHunyadyLAngiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone productionEndocrinology19921303163716441311245
- AzizanEAPoulsenHTulucPSomatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertensionNat Genet20134591055106023913004
- SchollUIGohGStöltingGSomatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronismNat Genet20134591050105423913001
- KontakACWangZArbiqueDReversible sympathetic overactivity in hypertensive patients with primary aldosteronismJ Clin Endocrinol Metab201095104756476120660053
- MenonDVArbiqueDWangZAdams-HuetBAuchusRJVongpatanasinWDifferential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patientsJ Clin Endocrinol Metab20099441361136619158191
- RahejaPPriceAWangZSpironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patientsHypertension201260231932522733474
- WeberKTBrillaCGPathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone systemCirculation1991836184918651828192
- YoungMFullertonMDilleyRFunderJMineralocorticoids, hypertension, and cardiac fibrosisJ Clin Invest19946936257825838200995
- RochaRRudolphAEFrierdichGEAldosterone induces a vascular inflammatory phenotype in the rat heartAm J Physiol Heart Circ Physiol20022835H1802H181012384457
- SatoASarutaTAldosterone-induced organ damage: plasma aldosterone level and inappropriate salt statusHypertens Res200427530331015198476
- PimentaEGordonRDAhmedAHCardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control studyJ Clin Endocrinol Metab20119692813282021632817